Abstract:The increasing incidence of bladder cancer and its high rate of recurrence over a 5-year period necessitate the need for diagnosis and surveillance amelioration. Cystoscopy and urinary cytology are the current tools, and molecular techniques such as BTA stat, NMP22, survivin mRNA, and urovysion FISH have attracted attention; however, they suffer from insufficient sensitivity or specificity. We developed a novel microfluidic approach for harvesting intact urinary-exfoliated tumor cells (UETC), either individually or in clusters, in a clean and segregated environment, which is crucial to minimize cross-contamination and misreads. To reliably and accurately identify UETC, our quantitative immunoassay involved concurrent use of two oncoproteins CK20 and CD44v6 antigen. CK20 is an intermediate filament protein overexpressed in urothelial tumors, and CD44v6 is a membrane adhesion molecule closely associated with cell invasion, tumor progression, and metastatic spread. Single-cell whole-genome sequencing on 12 captured UETCs and copy number alteration analysis showed that 11/12 (91.7%) of the immunofluorescence-identified UETCs possessed genomic instability. A total of 79 patients with bladder cancer and 43 age-matched normal controls (NC) were enrolled in the study. We detected considerably higher UETC counts in patients with bladder cancer versus the NC group [53.3 (10.7-1001.9) vs. 0.0 (0-3.0) UETCs/10 mL; P < 0.0001]. For bladder cancer detection, a stratified 10-fold cross-validation of training data reveals an overall predictive accuracy of 0.84 [95% confidence interval (CI), 0.76-0.93] with an 89.8% (95% CI, 71.5%-86.4%) for sensitivity and 71.5% (95% CI, 59.7%-83.3%) for specificity. Overall, the microfluidic immunoassay demonstrates increased sensitivity and specificity compared with other techniques for the detection of bladder cancer.Significance: A unique and promising diagnostic assay for bladder cancer is proposed with potential clinical utility as a complement for cytology. Cancer Res; 78(14); 4073-85. ©2018 AACR.

Antibody-modified Hydroxyapatite Surfaces for the Efficient Capture of Bladder Cancer Cells in a Patient's Urine Without Recourse to Any Sample Pre-Treatment

A Molecular Beacon Based Surface-Enhanced Raman Scattering Nanotag for Noninvasive Diagnosis of Bladder Cancer

A Fluorescence-Quenching Platform Based on Biomineralized Hydroxyapatite from Natural Seashell and Applied to Cancer Cell Detection.

Bladder Cancer Hunting: A Microfluidic Paper‐based Analytical Device

Non-invasive Diagnosis of Bladder Cancer by Detecting Telomerase Activity in Human Urine Using Hybridization Chain Reaction and Dynamic Light Scattering

Diagnosis of early-stage bladder cancer via unprocessed urine samples at the point of care

Design of a Microfluidic Chip for Bladder Cancer Cell Capturing in Urine

Selective capture of circulating tumor cells by antifouling nanostructure substrate made of hydrogel nanoparticles

Transparent, Biocompatible Nanostructured Surfaces for Cancer Cell Capture and Culture.

Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.

Dual SERS enhancement based on Ag@Au Nanopizza combined with superhydrophobic silicon substrate for the detection of early bladder cancer marker-APOA1

Non-invasive detection of bladder cancer via microfluidic immunoassay of the protein biomarker NMP22

Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor Cells

Photostable Cascade Activatable Peptide Self‐assembly on a Cancer Cell Membrane for High‐Performance Identification of Human Bladder Cancer

Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles

Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer

Microchips for Detection of Exfoliated Tumor Cells in Urine for Identification of Bladder Cancer

Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells

A simple fabricated microfluidic chip for urine sample-based bladder cancer detection

Data from Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification

Artificially Intelligent Olfaction for Fast and Noninvasive Diagnosis of Bladder Cancer from Urine